Personalized Depression Treatment System Using Molecular Data Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current mental disorder treatment planning is hindered by the inefficiency of finding effective therapies due to inconclusive treatment results, high costs of genetic testing, lack of standardized data capture, and inadequate integration of new data into existing databases, leading to suboptimal treatment outcomes for patients with psychiatric disorders like depression.
Innovation Solution
A system that combines molecular and clinical data to generate personalized treatment plans by analyzing patient-specific genetic and clinical information, using a therapy engine to provide recommendations on drug dosing, risks, and contraindications, and an interface for physicians to access and update treatment data efficiently.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional trial and error methodology is used to find effective therapy, then physicians can prescribe available antidepressants and antipsychotics, but treatment efficacy is low with more than 70% of patients failing to respond to first therapy
Solution Approach 1:
The system performs preliminary analysis of patient's molecular data (genetic, proteomic, metabolomic profiles) before treatment initiation to predict treatment response. This advance characterization allows physicians to select the most likely effective therapy from the outset, rather than relying on trial and error after treatment begins.
Solution Approach 2:
The patent replaces the mechanical trial-and-error process with an information-based decision system. By substituting empirical guessing with computational analysis of molecular data and treatment outcome predictions, the system eliminates the need for repeated unsuccessful treatment attempts.
2Measurement precision
If comprehensive molecular data is collected and analyzed to personalize treatment, then treatment precision is improved, but system complexity and cost increase due to multiple data types and advanced analytics
Solution Approach 1:
The system employs a multi-functional therapy engine that handles diverse data types (genomic, proteomic, metabolomic, clinical) through a unified analytical framework. This single platform performs multiple functions: data integration, pattern recognition, treatment prediction, and recommendation generation, eliminating the need for separate systems for each function.
Solution Approach 2:
The patent introduces a therapy engine as an intermediary layer between raw molecular data and clinical decision-making. This intermediary processes complex multi-omics data, translates it into actionable treatment predictions, and presents simplified recommendations to physicians, bridging the gap between complex data and practical application.
3Loss of information
If extensive molecular and clinical data is collected from patients, then treatment prediction accuracy is improved, but data management and integration into existing databases becomes inadequate and inefficient
Solution Approach 1:
The system merges previously siloed data types (molecular profiles, clinical records, treatment outcomes) into a unified database structure. By combining these diverse data sources into a single integrated system, the patent enables comprehensive analysis while improving data accessibility and integration efficiency.
Solution Approach 2:
The database system is designed to be dynamic and adaptive, automatically updating and reorganizing data as new information becomes available. The system evolves to incorporate new data types and analytical methods, maintaining efficiency while accommodating growing data complexity.
Data Source
AI summary
A system for personalized depression disorder treatment is disclosed herein. The system includes a server configured to communicate with existing healthcare resources and to receive patient data corresponding to a patient, the server including an analytics module. The system further includes a first database configured to store empirical patient outcomes, and further configured to communicate with the analytics module. Additionally, the system includes a user device having a graphical user interface (GUI) configured to communicate with the server and to display at least one output generated by the analytics module. The analytics module is configured to determine at least one of a personalized depression treatment and a personalized depression state prediction based on the empirical patient outcomes and the patient data.